EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

EUDA Health Holdings LimitedNASDAQ: EUDA

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 37.0%

Gross margin was 37.0% in Q2 FY2026, up 9.6 pp from a year earlier. On a trailing-twelve-month basis it was 44.0%, up 21.6 pp year over year. Over 3 fiscal years it widened by 20.8 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
37.0%+0.0 pp QoQ
Last fiscal yearDec 2025
43.9%+24.9 pp YoY
LTMJun 2026
44.0%+21.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+9.6 pp——
1 year+24.9 pp——
3 years+20.8 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
43.9%
Year-over-year change
+24.9pp

Gross Margin vs competitors

How EUDA compares with its peers on the latest reported figures

  • EUDA's LTM Jun 2026 gross margin of 44.0% is the 4th highest of the 7 companies compared; the peer median is 45.0%.
  • Its year-over-year change of +21.6 pp is the highest of 6, against a peer median of -1.0 pp.
  • Over three fiscal years its change of +20.8 pp compares with a peer median of -7.5 pp.
EUDA Competitors Peer median
Gross Margin for EUDA and competitors
Company Period LTM level YoY 3-year change
DTILPrecision BioSciences, Inc.LTM Mar 202697.0% -3.0 pp-8.0 pp
HYPRHyperfine, Inc.LTM Mar 202651.2% +5.0 pp+36.5 pp
AMWLAmerican Well CorporationLTM Mar 202649.7% +5.4 pp+11.2 pp
EUDAEUDA Health Holdings LimitedLTM Jun 202644.0% +21.6 pp+20.8 pp
FONRFONAR CorporationLTM Mar 202640.3% -1.0 pp-7.1 pp
ZTEKZentek Ltd.LTM Mar 2026-2522.4% -2545.1 pp-2714.2 pp
ATYRaTyr Pharma, Inc.LTM Mar 2026-11754.7% —-801.0 pp
GUTSFractyl Health, Inc. Common StockFY2025— ——
Peer median (excluding EUDA) 45.0%-1.0 pp-7.5 pp

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.56M3.76M3.71M4.01M6.82M
Cost of Revenue3.31M2.89M2.86M3.25M3.83M
Gross Profit1.25M870K842.08K762.16K2.99M
Gross Margin27.4%23.1%22.7%19.0%43.9%
Research & Development129.27K17.21K00249
Selling, General & Admin1.81M6.75M4.8M3.34M5.43M
Operating Expenses1.81M13.09M4.8M18.1M5.43M
Depreciation & Amortization264.1K172.02K119.35K173.22K406.48K
EBITDA1.34M(24.64M)(8.29M)(17.42M)(2.09M)
EBITDA Margin29.4%-654.6%-223.7%-434.4%-30.7%
Operating Income(559.99K)(5.72M)(3.96M)(17.34M)(2.44M)
Operating Margin-12.3%-151.9%-106.9%-432.2%-35.8%
Interest Income1.92M0000
Interest Expense127.13K93.78K23.23K44.89K228.62K
Other Income / Expenses2.23M(19.21M)(4.47M)(307.38K)(285.26K)
Income Before Tax1.67M(24.93M)(8.43M)(17.64M)(2.73M)
Pre-Tax Margin36.6%-662.3%-227.6%-439.8%-40.0%
Income Tax Expense46.49K(20.79K)0(4.38K)41.94K
Net Income864.83K(24.88M)(10.04M)(15.36M)(2.77M)
Net Margin19.0%-661.1%-270.9%-382.9%-40.7%
EPS (Basic)1.87(41.40)(8.80)(9.40)(1.49)
EPS (Diluted)1.87(41.40)(8.80)(9.40)(1.49)
Weighted Avg Shares462.67K601.48K1.15M1.62M1.86M
Weighted Avg Shares (Diluted)462.67K601.48K1.15M1.62M1.86M

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.